JESSICA TRAN: Open Payments
NPI 1013490606 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 28 payments from 8 companies in 2025. Trend: 2023 $395 · 2024 $416 · 2025 $753
Food & beverage: $681Education: $72
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 15 | $340 |
| AstraZeneca Pharmaceuticals LP | 2 | $151 |
| UCB, Inc. | 6 | $106 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: Zoryve, BREZTRI, Bimzelx, DUPIXENT, AIRSUPRA, APTIMA, MOUNJARO, ACCRUFER.
Industry payments across CA — which companies pay providers there.
